Epicenter Technology
1
9M
1
0.05
- Areas of investment
Summary
In 2000 was created Epicenter Technology, which is appeared as Corporate Investor. The company was established in Asia in India. The main department of described Corporate Investor is located in the Mumbai.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Canada. Among the most popular fund investment industries, there are Therapeutics, Health Care. Among the various public portfolio startups of the fund, we may underline Alethia BioTherapeutics
The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 5 - 10 millions dollars. The top activity for fund was in 2010.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Epicenter Technology, startups are often financed by GO Capital Fund, BDC Venture Capital. The meaningful sponsors for the fund in investment in the same round are GO Capital Fund, BDC Venture Capital, AgeChem Venture Fund. In the next rounds fund is usually obtained by GO Capital Fund, BDC Venture Capital, AgeChem Venture Fund.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Rounds per year
- 0.05
- Investments by industry
- Health Care (1)
- Therapeutics (1)
- Biotechnology (1)
- Investments by region
-
- Canada (1)
- Peak activity year
- 2010
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Alethia BioTherapeutics | 07 Sep 2010 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 9M | Canada, Quebec, Montreal |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.